What is Gem?
Established in 2018 and headquartered in Los Angeles, California, Gem is at the forefront of pioneering new applications within the consumer life science domain. The company's core mission revolves around advancing human and planetary nutrition through proprietary scientific advancements. Gem's innovative approach positions it as a key player in a rapidly evolving market, attracting substantial investment interest for its unique contributions to health and sustainability.
How much funding has Gem raised?
Gem has raised a total of $11.7M across 3 funding rounds:
Angel/Seed
$3.3M
Other Financing Round
$1.3M
Series A
$7.1M
Angel/Seed (2015): $3.3M with participation from RRE Ventures, Baseline Ventures, KEC Ventures, Tekton Ventures, QED Associates, Baroda Ventures, Birchmere Labs, Bitcoin Shop, Inc., Wavemaker Labs, and Amplify.La Capital II
Other Financing Round (2015): $1.3M led by KEC Ventures, RRE Ventures, and Baseline Ventures
Series A (2016): $7.1M, investors not publicly disclosed
Key Investors in Gem
KEC Ventures
KEC Ventures is a venture capital firm that engages in a broad range of investment activities, investing in everything from early-stage technology-enabled startups to late-stage private equity transactions. They possess the flexibility to invest in a wide variety of asset classes and actively pursue the development of in-house intellectual property.
RRE Ventures
RRE Ventures is a venture capital firm dedicated to supporting founders at critical stages of their business journey. The firm invests in a diverse portfolio of startups, focusing on long-term partnerships with entrepreneurs and backing exceptional teams and innovative ideas.
Baseline Ventures
Baseline Ventures is a venture capital firm that invests in innovative startups across various sectors, focusing on supporting entrepreneurs and helping them achieve significant results. Their portfolio includes companies in finance, technology, and consumer services.
What's next for Gem?
The recent major strategic investment signals a pivotal phase for Gem, likely enabling accelerated product development, market expansion, and further research into novel nutritional solutions. This infusion of capital is expected to bolster the company's efforts to scale its operations and solidify its position as a leader in the consumer life science industry, particularly in the critical areas of human and planetary well-being. Gem's strategic financing indicates a strong investor confidence in its long-term vision and potential for significant impact.
See full Gem company page
